NLAAD Announces 2023 Webinar Series with Special Focus on Latinos Accessing PrEP
Post

NLAAD Announces 2023 Webinar Series with Special Focus on Latinos Accessing PrEP

The NLAAD webinar series will kick off TODAY at 3PM ET with a discussion about what is needed to make PrEP into the hands of everyone who needs it. Review the webinar listing below and register now to take part in these important conversations. Webinars are open to everyone. The sessions will include time for...

September 26, 2023October 5, 2023by
Geographic mobility impacts vulnerability to HIV among gay and bisexual Latino migrants to the US
Post

Geographic mobility impacts vulnerability to HIV among gay and bisexual Latino migrants to the US

Gay and bisexual Latino migrants in the United States, especially but not only those who are undocumented, are vulnerable to higher rates of sexual risk behaviours and HIV transmission, a recent study published in Social Science and Medicine found. The study identified homophobia and HIV related stigma in their residential communities, barriers to well-paid work,...

May 5, 2023October 5, 2023by
NLAAD: HIV in Hispanics/Latinos During the year 2020
Post

NLAAD: HIV in Hispanics/Latinos During the year 2020

Credits: this summary of the impact of HIV among Hispanics/Latinos by gender, sexual orientation and age group has been prepared by Luis A. Mares, LMSW   GENERAL Hispanic/Latino Americans in the United States have to deal with a variety of social determinants of health that put them in a precarious position when it comes to...

October 11, 2022October 11, 2022by
Registrations Open for NLAAD Webinar Series 2022
Post

Registrations Open for NLAAD Webinar Series 2022

Tuesday October 4th, 3pm “A different PrEP Option: A Presentation for PrEP Professionals” Apretude is the first and only long acting injectable PrEP for reducing the risk of getting HIV. Join us to this presentation given by ViiV laboratories with information about this new important medical advance in the HIV field. [Registration link]   Wednesday...

October 5, 2022October 5, 2022by
U.S. FDA Approves CABENUVA for Use Every Two Months, Expanding the Label of the First and Only Long-Acting HIV Treatment
Post

U.S. FDA Approves CABENUVA for Use Every Two Months, Expanding the Label of the First and Only Long-Acting HIV Treatment

TITUSVILLE, N.J., February 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved an expanded label for CABENUVA (rilpivirine and cabotegravir) to be administered every two months for the treatment of HIV-1 in virologically suppressed adults (HIV-1 RNA less than 50 copies per...

February 1, 2022October 5, 2023by
AIDSVu Recognizes National Latinx AIDS Awareness Day
Post

AIDSVu Recognizes National Latinx AIDS Awareness Day

October 15 is National Latinx AIDS Awareness Day (NLAAD). This year’s theme, “Ending HIV is at your fingertips,” focuses on the tools already available to address the HIV epidemic, like HIV testing, PrEP, condom use, HIV treatment, and U=U, as we are dealing with the COVID-19 pandemic. Historically, HIV has disproportionately impacted Hispanic/Latinx Americans, and a broad...

October 15, 2020October 31, 2020by
NLAAD Presentation at Loisaida TV
Post

NLAAD Presentation at Loisaida TV

Luis A Mares, LMSW , Director of Community Mobilization at the Latino Commission on AIDS was invited by the Loisaida Center TV from Acacia network, for one episode in their programing, to talk about NLAAD and the work the Commission does about not just on awareness about HIV in the Latinx Community, but about all...

October 14, 2020October 30, 2020by
Ryan White and Latinx AIDS Awareness Day
Post

Ryan White and Latinx AIDS Awareness Day

Latinos represent 26% of new HIV diagnoses in the United States, but make only 18.3% of the overall population (CDC, 2020). Most new HIV cases among Latinos are among men who have sex with men, MSM; these increases are concentrated in Arizona, California, Florida, Illinois, New York, Texas, and Puerto Rico (CDC, 2018). Nearly three-quarters of RWHAP clients are from racial/ethnic minority populations. According to the 2018 HRSA client...

October 7, 2020October 7, 2020by
Register for the Latest News: Advancing the Ending the HIV Epidemic Initiative during COVID-19
Post

Register for the Latest News: Advancing the Ending the HIV Epidemic Initiative during COVID-19

The Latino Commission on AIDS (LCOA) will host a webinar entitled “Advancing the Ending the HIV Epidemic Initiative during COVID-19” on Wednesday, October 14th. Guest speaker Harold Phillips, Chief Operating Officer of the Ending the HIV Epidemic: A Plan for America(EHE) initiative, will talk about EHE’s goals and how to achieve them while navigating the...

October 7, 2020October 7, 2020by